Inovio Pharmaceuticals, Inc.
PD1 AND PDL1 ANTIBODIES AND VACCINE COMBINATIONS AND USE OF SAME FOR IMMUNOTHERAPY

Last updated:

Abstract:

Disclosed herein is a vaccine comprising an antigen and PD1 antibody and/or PDL1 antibody. Also disclosed herein is a method for enhancing an immune response in a subject. The method may comprise administering the vaccine to the subject in need thereof.

Status:
Application
Type:

Utility

Filling date:

6 Oct 2020

Issue date:

25 Mar 2021